Depression is a frequent co-morbidity in patients with acne inversa;Depression bei Patienten mit Acne inversa-eine häufige Komorbidität

JDDG - Journal of the German Society of Dermatology

Volumn 11, Issue 8, 2013, Pages 743-749

  Kurek, Agata ^a   Johanne Peters, Eva Milena ^a,b   Sabat, Robert ^a   Sterry, Wolfram ^a   Schneider Burrus, Sylke ^a  

^a CHARITÉ UNIVERSITÄTSMEDIZIN BERLIN   (Germany)

^b JUSTUS LIEBIG UNIVERSITY   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

ACNE; ADULT; ANXIETY; ARTICLE; BODY MASS; COMORBIDITY; CONTROLLED STUDY; DEPRESSION; DISEASE DURATION; DISEASE SEVERITY; DISTRESS SYNDROME; FEMALE; HOSPITAL ANXIETY AND DEPRESSION SCALE; HUMAN; INFLAMMATION; MAJOR CLINICAL STUDY; MALE; SEX; ACNE INVERSA; CLINICAL ARTICLE; INFLAMMATORY DISEASE; SEXUAL DISTRESS;

ADULT; AGE DISTRIBUTION; ANXIETY; BODY DYSMORPHIC DISORDERS; CAUSALITY; COMORBIDITY; DEPRESSION; FEMALE; GERMANY; HIDRADENITIS SUPPURATIVA; HUMANS; INCIDENCE; MALE; RISK FACTORS; SEX DISTRIBUTION; YOUNG ADULT;

C REACTIVE PROTEIN;

EID: 84880920598     PISSN: 16100379     EISSN: 16100387     Source Type: Journal    
DOI: 10.1111/ddg.12067     Document Type: Article

References (45)

1. Meixner D, Schneider S, Krause M, Sterry W,. Acne inversa. J Dtsch Dermatol Ges 2008; 6: 189-96.
2. Alikhan A, Lynch PJ, Eisen DB,. Hidradenitis suppurativa: a comprehensive review. J Am Acad Dermatol 2009; 60: 539-61; quiz 62-3.
3. Jemec GB, Heidenheim M, Nielsen NH,. The prevalence of hidradenitis suppurativa and its potential precursor lesions. J Am Acad Dermatol 1996; 35: 191-4.
4. Revuz JE, Canoui-Poitrine F, Wolkenstein P, Viallette C, Gabison G, Pouget F, Poli F, Faye O, Roujeau JC, Bonnelye G, Grob JJ, Bastuji-Garin S,. Prevalence and factors associated with hidradenitis suppurativa: results from two case-control studies. J Am Acad Dermatol 2008; 59: 596-601.
5. Sabat R, Chanwangpong A, Schneider-Burrus S, Metternich D, Kokolakis G, Kurek A, Philipp S, Uribe D, Wolk K, Sterry W,. Increased prevalence of metabolic syndrome in patients with acne inversa. PLoS One 2012; 7: e31810.
6. von der Werth JM, Jemec GB,. Morbidity in patients with hidradenitis suppurativa. Br J Dermatol 2001; 144: 809-13.
7. Wolkenstein P, Loundou A, Barrau K, Auquier P, Revuz J,. Quality of life impairment in hidradenitis suppurativa: a study of 61 cases. J Am Acad Dermatol. 2007; 56: 621-3.
8. Matusiak L, Bieniek A, Szepietowski JC,. Psychophysical aspects of hidradenitis suppurativa. Acta Derm Venereol. 2010; 90: 264-8.
9. Matusiak L, Bieniek A, Szepietowski JC,. Hidradenitis suppurativa markedly decreases quality of life and professional activity. J Am Acad Dermatol 2010; 62: 706-8, 08 e1.
10. Jemec GB, Heidenheim M, Nielsen NH,. Hidradenitis suppurativa- characteristics and consequences. Clin Exp Dermatol 1996; 21: 419-23.
11. Kurek A, Peters EM, Chanwangpong A, Sabat R, Sterry W, Schneider-Burrus S,. Profound disturbances of sexual health in patients with acne inversa. J Am Acad Dermatol 2012; 67: 422-8, 28 e1.
12. Klassen AF, Newton JN, Mallon E,. Measuring quality of life in people referred for specialist care of acne: comparing generic and disease-specific measures. J Am Acad Dermatol 2000; 43: 229-33.
13. Gladman DD, Mease PJ, Cifaldi MA, Perdok RJ, Sasso E, Medich J,. Adalimumab improves joint-related and skin-related functional impairment in patients with psoriatic arthritis: patient-reported outcomes of the Adalimumab Effectiveness in Psoriatic Arthritis Trial. Ann Rheum Dis 2007; 66: 163-8.
14. Revicki D, Willian MK, Saurat JH, Papp KA, Ortonne JP, Sexton C, Camez A,. Impact of adalimumab treatment on health-related quality of life and other patient-reported outcomes: results from a 16-week randomized controlled trial in patients with moderate to severe plaque psoriasis. Br J Dermatol 2008; 158: 549-57.
15. Ermertcan AT, Gencoglan G, Temeltas G, Horasan GD, Deveci A, Ozturk F,. Sexual dysfunction in female patients with neurodermatitis. J Androl 2011; 32: 165-9.
16. Williamson D, Gonzalez M, Finlay AY,. The effect of hair loss on quality of life. J Eur Acad Dermatol Venereol 2001; 15: 137-9.
17. Harris A, Burge SM, Dykes PJ, Finlay AY,. Handicap in Darier's disease and Hailey-Hailey disease. Br J Dermatol 1996; 135: 959-63.
18. Alonso J, Angermeyer MC, Lepine JP,. The European Study of the Epidemiology of Mental Disorders (ESEMeD) project: an epidemiological basis for informing mental health policies in Europe. Acta Psychiatr Scand Suppl 2004: 5-7.
19. Kessler RC, Berglund P, Demler O, Jin R, Koretz D, Merikangas KR, Rush AJ, Walters EE, Wang PS,. The epidemiology of major depressive disorder: results from the National Comorbidity Survey Replication (NCS-R). JAMA 2003; 289: 3095-105.
20. Hasin DS, Goodwin RD, Stinson FS, Grant BF,. Epidemiology of major depressive disorder: results from the National Epidemiologic Survey on Alcoholism and Related Conditions. Arch Gen Psychiatry 2005; 62: 1097-106.
21. Dantzer R, O'Connor JC, Freund GG, Johnson RW, Kelley KW,. From inflammation to sickness and depression: when the immune system subjugates the brain. Nat Rev Neurosci 2008; 9: 46-56.
22. Haroon E, Raison CL, Miller AH,. Psychoneuroimmunology meets neuropsychopharmacology: translational implications of the impact of inflammation on behavior. Neuropsychopharmacology 2012; 37: 137-62.
23. Richards HL, Fortune DG, Griffiths CE, Main CJ,. The contribution of perceptions of stigmatisation to disability in patients with psoriasis. J Psychosom Res 2001; 50: 11-5.
24. Wittkowski A, Richards HL, Griffiths CE, Main CJ,. The impact of psychological and clinical factors on quality of life in individuals with atopic dermatitis. J Psychosom Res 2004; 57: 195-200.
25. Golchai J, Khani SH, Heidarzadeh A, Eshkevari SS, Alizade N, Eftekhari H,. Comparison of anxiety and depression in patients with acne vulgaris and healthy individuals. Indian J Dermatol 2010; 55: 352-4.
26. Yazici K, Baz K, Yazici AE, Kokturk A, Tot S, Demirseren D, Buturak V,. Disease-specific quality of life is associated with anxiety and depression in patients with acne. J Eur Acad Dermatol Venereol 2004; 18: 435-9.
27. Esmann S, Jemec GB,. Psychosocial Impact of Hidradenitis Suppurativa: A Qualitative Study. Acta Derm Venereol 2011; 91 (3): 328-32.
28. Onderdijk AJ, van der Zee HH, Esmann S, Lophaven S, Dufour DN, Jemec GB, Boer J,. Depression in patients with hidradenitis suppurativa. J Eur Acad Dermatol Venereol 2012 Feb 20. [Epub ahead of print].
29. Hidradentitis Suppurativa Foundation (HSF). Second International Conference on hidradentitis suppurativa, San Francisco, Ca, March 5, 2009. Available from: www.hs-foundation.org. Accessed 18 June, 2011.
30. Sartorius K, Lapins J, Emtestam L, Jemec GB,. Suggestions for uniform outcome variables when reporting treatment effects in hidradenitis suppurativa. Br J Dermatol 2003; 149: 211-3.
31. Sartorius K, Emtestam L, Jemec GB, Lapins J,. Objective scoring of hidradenitis suppurativa reflecting the role of tobacco smoking and obesity. Br J Dermatol 2009; 161: 831-9.
32. Zigmond AS, Snaith RP,. The hospital anxiety and depression scale. Acta Psychiatr Scand 1983; 67: 361-70.
33. Herrmann C,. International experiences with the Hospital Anxiety and Depression Scale-a review of validation data and clinical results. J Psychosom Res 1997; 42: 17-41.
34. Olssøn I, Mykletun A, Dahl AA,. The Hospital Anxiety and Depression Rating Scale: a cross-sectional study of psychometrics and case finding abilities in general practice. BMC Psychiatry 2005; 5: 46.
35. Deusinger IM., [Measurement of change in self-concept with the Frankfurt self-concept scales]. Z Gerontol 1982; 15: 42-5.
36. Beck AT, Ward CH, Mendelson M, Mock J, Erbaugh J,. An inventory for measuring depression. Arch Gen Psychiatry 1961; 4: 561-71.
37. Hurley HJ,. Axillary hyperhidrosis, apocrine bromhidrosis, hidradenitis suppurativa, and familial benign pemphigus: surgical approach. In: Roenigk RK, Roenigk HH: Dermatologic Surgery, Principles and Practice. New York: Marcel Dekker, 1989: 729-39.
38. Bech P, Rasmussen NA, Olsen LR, Noerholm V, Abildgaard W,. The sensitivity and specificity of the Major Depression Inventory, using the Present State Examination as the index of diagnostic validity. J Affect Disord 2001; 66: 159-64.
39. Bostwick JM, Pankratz VS,. Affective disorders and suicide risk: a reexamination. Am J Psychiatry 2000; 157: 1925-32.
40. Elovainio M, Aalto AM, Kivimaki M, Pirkola S, Sundvall J, Lonnqvist J, Reunanen A,. Depression and C-reactive protein: population-based Health 2000 Study. Psychosom Med 2009; 71: 423-30.
41. Morris AA, Zhao L, Ahmed Y, Stoyanova N, De Staercke C, Hooper WC, Gibbons G, Din-Dzietham R, Quyyumi A, Vaccarino V,. Association between depression and inflammation-differences by race and sex: the META-Health study. Psychosom Med 2011; 73: 462-8.
42. Suarez EC,. C-reactive protein is associated with psychological risk factors of cardiovascular disease in apparently healthy adults. Psychosom Med 2004; 66: 684-91.
43. Copeland WE, Shanahan L, Worthman C, Angold A, Costello EJ,. Cumulative depression episodes predict later C-reactive protein levels: a prospective analysis. Biol Psychiatry 2012; 71: 15-21.
44. Boden JM, Fergusson DM, Horwood LJ,. Cigarette smoking and depression: tests of causal linkages using a longitudinal birth cohort. Br J Psychiatry 2010; 196: 440-6.
45. Akbaraly TN, Kivimaki M, Brunner EJ, Chandola T, Marmot MG, Singh-Manoux A, Ferrie JE,. Association between metabolic syndrome and depressive symptoms in middle-aged adults: results from the Whitehall II study. Diabetes Care 2009; 32: 499-504.